Shaw LJ - Search Results

1

Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications.

Shaw LJ. Shaw LJ. Clin Cardiol. 1997 Oct;20(10 Suppl 1):I39-48. doi: 10.1002/clc.4960201309. Clin Cardiol. 1997. PMID: 9383601 Free PMC article.

2

Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings.

Shaw LJ, Dittrich HC. Shaw LJ, et al. Acad Radiol. 1998 Apr;5 Suppl 1:S250-1; discussion S252-3. doi: 10.1016/s1076-6332(98)80120-7. Acad Radiol. 1998. PMID: 9561093 No abstract available.

3

Outcomes assessment and disease management strategies in diagnostic imaging: creating value and quality with nuclear cardiology.

Shaw LJ, Hachamovitch R, Thomas G. Shaw LJ, et al. J Cardiovasc Manag. 1998 Sep-Oct;9(5):10-8. J Cardiovasc Manag. 1998. PMID: 10185107

4

Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group.

Shaw LJ, Gillam L, Feinstein S, Dent J, Plotnick G. Shaw LJ, et al. Am J Manag Care. 1998 Sep 25;4 Spec No:SP169-76. Am J Manag Care. 1998. PMID: 10185992 Free article. Clinical Trial.

5

Clinical and economic outcomes assessment with myocardial contrast echocardiography.

Shaw LJ, Monaghan MJ, Nihoyannopolous P. Shaw LJ, et al. Heart. 1999 Nov;82 Suppl 3(Suppl 3):III16-21. doi: 10.1136/hrt.82.2008.iii16. Heart. 1999. PMID: 10534326 Free PMC article. Review. No abstract available.

6

Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]).

Alazraki NP, Krawczynska EG, Kosinski AS, DePuey EG 3rd, Ziffer JA, Taylor AT Jr, Pettigrew RI, Vansant JP, Shaw LJ, Weintraub WS, King SB 3rd. Alazraki NP, et al. Among authors: shaw lj. Am J Cardiol. 1999 Dec 15;84(12):1369-74. doi: 10.1016/s0002-9149(99)00578-0. Am J Cardiol. 1999. PMID: 10606106 Clinical Trial.

7

Clinical and economic outcomes assessment in nuclear cardiology.

Shaw LJ, Miller DD, Berman DS, Hachamovitch R. Shaw LJ, et al. Q J Nucl Med. 2000 Jun;44(2):138-52. Q J Nucl Med. 2000. PMID: 10967624 Review.

8

Economic aspects of transesophageal echocardiography and atrial fibrillation.

Becker ER, Culler SD, Shaw LJ, Weintraub WS. Becker ER, et al. Among authors: shaw lj. Echocardiography. 2000 May;17(4):407-18. doi: 10.1111/j.1540-8175.2000.tb01156.x. Echocardiography. 2000. PMID: 10979013

9

Methodological considerations in the assessment of noninvasive testing using outcomes research: pitfalls and limitations.

Hachamovitch R, Shaw L, Berman DS. Hachamovitch R, et al. Prog Cardiovasc Dis. 2000 Nov-Dec;43(3):215-30. doi: 10.1053/pcad.2000.19313. Prog Cardiovasc Dis. 2000. PMID: 11153509 Review.

10

Current evidence on diagnostic testing in women with suspected coronary artery disease: choosing the appropriate test.

Shaw LJ, Hachamovitch R, Redberg RF. Shaw LJ, et al. Cardiol Rev. 2000 Jan-Feb;8(1):65-74. doi: 10.1097/00045415-200008010-00011. Cardiol Rev. 2000. PMID: 11174875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

846 results

Search Page